Together with our other genetic evidence, our BACE1-YFP transgenic results strongly support the conclusion that amyloid-associated BACE1 elevation occurs via a mechanism that is independent of eIF2α phosphorylation. This evidence concerns the gene EIF2A and amyloidosis.